FEops Closes EUR 6 Million in Series B Financing

FEops, a leader in personalized computer modeling for structural heart interventions, announced today that it has secured six million euros in Series B investment. The round was led by Valiance and joined by existing investors Capricorn and PMV.

FEops’ proprietary array of products uses advanced computer simulations to provide clinicians and valve manufacturers with first-ever insights into the interaction between valve and specific patient anatomy – preoperatively. Such insights have tremendous power to accelerate research and development of novel valve-based solutions, as well as ultimately to improve clinical outcomes in real-world hospital settings.

The funding will be used to implement the company’s product roadmap and drive commercial adoption in the fast-growing market for transcatheter valve therapies.